AMPULIS INC.

From the company

Ampulis develops Pristal, a dual-chamber syringe (DCS) that reconstitutes lyophilized biologics from two independent, standard cartridges rather than stacked coaxial chambers. Removing the cap triggers an internal spring that pierces both cartridges and automatically transfers diluent into the lyo cartridge; the user then agitates to confirm reconstitution and doses with a single plunger stroke. Ampulis owns all Pristal IP, and Pristal is engineered with Archimedic covering design, verification, quality, and manufacturing transfer.